This page is maintained and edited by Hellen Popovich (Senior Editor at World Wide News Flash since May, 2009).
You can contribute to this page by sending an email to [email protected] or by using our contact form below.

Vectibix

August 11, 2010 Amgen?s Vectibix Fails In Head-And-Neck Cancer | Bone Cancer ... Send by Administrator Amgen?s Vectibix Fails In Head-And-Neck Cancer. Published August 11th, 2010 in Osteosarcoma News. 0 Comments. The colon cancer Vectibix did not improve survival in head-and-neck cancer, maker Amgen announced t. Read the rest here: [...] Rating: 3 out of 5 stars Rate up / Rate down Report to moderator

October 05, 2010 Prostaglandin Erection Posted by Hellen Popovich In contrast Daily Health. prostaglandin erection it is designed to estimate Vectibix was received much health authorities has shown of drug. We all had secondstage is a stop other are safe reached the body such. [...] Rating: 4 out of 5 stars Rate up / Rate down Report to moderator

August 11, 2010 First-line Vectibix Modestly Improves Colorectal Cancer Outcome ... Send by mjames Among patients with metastatic colorectal cancer, initial treatment with a combination of chemotherapy and Vectibix (panitumumab) delays cancer progression by 1.6 months compared with chemotherapy alone. [...] Rating: No stars. Rate up / Rate down Report to moderator

October 05, 2010 NIH Awards Pulmokine $650,000 To Develop Novel Treatments For PAH Send by www.news-medical.net YM BioSciences Inc., today reported that Pulmokine Inc. (Slingerlands, New York), a licensee of several small molecule compounds from YM, has been awarded two National Institutes of Health (NIH) Small Business Innovation Research (SBIR) grants. The grants, totaling more than US$650,000, are Phase I awards to develop novel treatments for Pulmonary Arterial Hypertension (PAH). [...] Rating: 5 out of 5 stars Rate up / Rate down Report to moderator

October 05, 2010 Analysis Of Vectibix(R) Study Using New Gene Technology Helps To ... Send by James COM/ Amgen (Nasdaq: AMGN) today announced detailed results from a new biomarker analysis of the pivotal Phase 3 408 trial of Vectibix (panitumumab) plus best supportive care (BSC) compared to BSC alone. [...] ' href='http://serkadis.com/index/532580'> [ [...] ] Rating: 2 out of 5 stars Rate up / Rate down Report to moderator

October 05, 2010 PIK3CA, MEK And Mutant KRAS In Cancer Posted by Hellen Popovich One of the current challenges with developing new targeted agents in oncology is the tendency to rush various agents, whether monoclonal antibodies (mAB) or tyrosine kinase inhibitors (TKIs) into the clinic before we know how they might best work or in what potential combinations based on the precis [...] Rating: 3 out of 5 stars Rate up / Rate down Report to moderator

October 05, 2010 - Send by релиз) (Блог) ( / Aranesp / Vectibix / Viread / Ever Flo [...] Rating: No stars. Rate up / Rate down Report to moderator

August 11, 2010 Colon Cancer And Chemotherapy Posted by Hellen Popovich If you have been diagnosed with colon cancer, you may be eligable for chemotherapy. Colon cancer chemotherapy is the use of anticancer drugs to kill colon cancer cells. There are several types of chemotherapy each of which have side effects. Chemotherapy Chemotherapy is a term used by doctors to ref [...] Rating: 4 out of 5 stars Rate up / Rate down Report to moderator

August 11, 2010 Vectibix, Panitumumab - Chemotherapy Drugs, Chemo Drug Side Effects Posted by Hellen Popovich Vectibix is classified as a monoclonal antibody and signal transduction inhibitor by binding to epidermal growth factor receptors (EGFR). Vectibix is used to treat colorectal [...] Rating: 2 out of 5 stars Rate up / Rate down Report to moderator

August 11, 2010 Marching Forward Posted by Hellen Popovich Well, the marathon at the hospital this morning went quite well. Amazing what you can get done in the time it takes to pay $13.50 in parking fees! I felt fairly comfortable when went to see the doctor - we were taken into a regular clinic room. If we had gone into the "pretty" room I would have been [...] Rating: 1 out of 5 stars Rate up / Rate down Report to moderator

August 11, 2010 Amgen Imploding: Vectibix Trial Halted // Pharmalot Posted by Hellen Popovich The biotech ended a key clinical trial of its Vectibix colon cancer med after discovering it reduced chances of survival. An interim peek at the data show patients treated only with chemo and Genentech's Avastin were more likely to live [...] Rating: 5 out of 5 stars Rate up / Rate down Report to moderator

October 05, 2010 Vectibix Does Not Improve Head And Neck Cancer Survival Posted by Hellen Popovich Among patients with recurrent and/or metastatic, squamous cell head and neck cancer, the addition of the targeted therapy Vectibix (panitumumab) to chemotherapy does not result in significantly better survival than chemotherapy alone. [...] Rating: No stars. Rate up / Rate down Report to moderator

October 05, 2010 Article > Amgen's Vectibix Fails In Head And Neck Cancer Posted by Hellen Popovich Shares in Amgen have slipped on the news that its colon cancer drug Vectibix has failed in a late-stage clinical trial to improve survival for patients with head and neck cancer compared to chemotherapy. [...] Rating: 2 out of 5 stars Rate up / Rate down Report to moderator

October 05, 2010 Analysis Of Vectibix(R) Study Using New Gene Technology Helps To ... Send by Biotechnology THOUSAND OAKS, Calif., April 18 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) today announced detailed results from a new biomarker analysis of the pivotal Phase 3 "408" trial of Vectibix (panitumumab) plus best supportive care (BSC) [...] Rating: 5 out of 5 stars Rate up / Rate down Report to moderator

August 11, 2010 Vectibix Information From Drugs.com Posted by Hellen Popovich Vectibix (panitumumab) treats metastatic colorectal cancer that has progressed after treatment with other chemotherapy. Includes Vectibix side effects, interactions and indications [...] Rating: 2 out of 5 stars Rate up / Rate down Report to moderator

---

Submit article

Name:
E-Mail:
Source:
Article:
Please complete all the fields in order to take your article in consideration.